About the Company
natera is a san carlos, ca-based company that is driven by a passion for elevating the science and utility of prenatal testing. the advent of the information age has created a paradigm shift in the fields of computing and informatics. surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. until natera. from conception to delivery, natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. the company offers a wide range of tests from preimplantation genetic diagnosis (pgd) for ivf to breakthrough advances in the field of non-invasive prenatal testing (nipt). using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NTRA News
Natera: Capitalizing On The Positive Momentum Of Personalized Medicine
Natera aims to achieve cash flow break even in Q3 2024 through its revenue growth in the women's health and oncology sectors.
Will Natera (NTRA) Continue to Deliver Solid Topline Growth?
After years of heavy investment to drive revenue growth, NTRA continues to deliver solid topline growth and is now on the ...
Natera, Inc. (NTRA) Q4 2023 Earnings Call Transcript
At this time, I would like to welcome everyone to the Natera Inc. Fourth Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks ...
Decoding Natera Inc (NTRA): A Strategic SWOT Insight
Insight into Natera Inc's innovative molecular and bioinformatics technology in healthcare. Examination of Natera Inc's financial health and market position. Identification of strategic ...
Natera (NTRA) Management Increased Full Year Guidance
Alger Weatherbie Specialized Growth Fund featured stocks like Natera, Inc. (NASDAQ:NTRA) in the Q4 2023 investor letter.
Natera Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Natera’s Strong Q4 Performance and Positive Outlook Merit Buy Rating and $90 Price Target
Begin your TipRanks Premium journey today. Natera (NTRA) Company Description: Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers ...
Natera Seeks Royalty For AlloSure Tests From CareDx In Patent Infringement Case
(RTTNews) - Diagnostics and research company, Natera, Inc. (NTRA), said on Tuesday that it would seek royalty for all ongoing and future AlloSure tests occurring after August 2023, from CareDx ...
Natera Inc earnings beat by $0.12, revenue topped estimates
Natera Inc sees FY 2024 revenue of $1.32B-$1.35B versus the analyst consensus of $1.27B. Natera Inc's stock price closed at $76.55. It is up 30.94% in the last 3 months and up 41.03% in the last 12 ...
Natera, Inc. (NASDAQ:NTRA) Q4 2023 Earnings Call Transcript
Natera, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by.
Loading the latest forecasts...